Joann A Reed

CIK 1252013 · SVP, Finance and CFO · last filed 2025-05-16

Joann A Reed is a SVP, Finance and CFO who has filed 72 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for AMT, was dated May 16, 2025. Across all open-market trades the lifetime net is −$18.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $27.1M across reported positions. 30 SEC filings were submitted jointly with AMERICAN TOWER CORP /MA/.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$27.08M

Companies

Total Filings

Lifetime Open-Market Net

-$18.40M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

C/O AMERICAN TOWER CORP
116 HUNTINGTON AVENUE
BOSTON, MA 02116

Related Filers

AMERICAN TOWER CORP /MA/ — 30 joint filings, latest 2025-05-16

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
AMT	Director	62,940	$162.20	$10.21M	-$3.41M	28	2025-05-16
Keenova Therapeutics plc (MNK) Delisted	Director	0	$0.34	$0	$17.5K	14	2022-03-21
WAT	Director	39,685	$425.21	$16.87M	-$4.46M	21	2021-03-08
HEALTH MANAGEMENT ASSOCIATES, INC (HMA) Delisted	Director	—	$10.54	—	$0	3	2014-01-27
DynaVox Inc. (DVOX) Delisted	Director	13,336	—	—	$0	2	2012-06-04
MEDCO HEALTH SOLUTIONS INC (MHS) Delisted	SVP, Finance and CFO	167,818	—	—	-$10.55M	3	2007-09-05

Recent Filings

72 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2025-05-16	AMT	—	—	$0	EDGAR
2025-03-12	AMT	Grant (A)	+1,056	$0	EDGAR
2024-03-12	AMT	Grant (A)	+1,089	$0	EDGAR
2023-11-13	AMT	Mixed	+5,169	-$11.0K	EDGAR
2023-11-09	AMT	Notice (144)	−4,856	-$891.4K	EDGAR
2023-03-14	AMT	Grant (A)	+1,072	$0	EDGAR
2022-11-01	AMT	Mixed	+2,008	-$3.1K	EDGAR
2022-03-21	Keenova Therapeutics plc (MNK) Delisted	Sell (S)	−34,065	-$4.0K	EDGAR
2022-03-14	AMT	Grant (A)	+881	$0	EDGAR
2021-11-18	AMT	Mixed	+2,724	-$3.0K	EDGAR

Showing 1–10 of 72

Page 1 of 8 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.